Posted at 04 Aug, 00:00h in News by alic 0 Comments ANA Therapeutics Announces U.S. FDA Clearance Of IND Application To Initiate Clinical Trial Of Niclosamide In COVID-19 Patients /PRNewswire/ — ANA Therapeutics (ANA), a Silicon Valley-based biotech start-up announced today that the U.S. Food and Drug Administration (FDA) has cleared… Tags: ANA Therapeutics ShareANA Therapeutics Announces U.S. FDA Clearance Of IND Application To Initiate Clinical Trial Of Niclosamide In COVID-19 Patients&media=', 'popupwindow', 'scrollbars=yes,width=800,height=400');popUp.focus();return false"> Print page 0 Likes
Sorry, the comment form is closed at this time.